MAIA MAIA Biotechnology Inc

Price (delayed)

$1.32

Market cap

$80.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$52.69M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 35
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend ...

Highlights
MAIA Biotechnology's quick ratio has soared by 119% YoY but it has decreased by 19% from the previous quarter
The EPS has declined by 9% year-on-year but it rose by 7% since the previous quarter
MAIA Biotechnology's net income has plunged by 66% YoY and by 11% from the previous quarter
MAIA's equity is down by 26% since the previous quarter

Key stats

What are the main financial stats of MAIA

MAIA stock price

How has the MAIA Biotechnology stock price performed over time
Intraday
-3.65%
1 week
-5.71%
1 month
-5.04%
1 year
-13.73%
YTD
-13.73%
QTD
-8.33%

Financial performance

How have MAIA Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$28.95M
Net income
-$26.85M
Gross margin
N/A
Net margin
N/A
MAIA Biotechnology's net income has plunged by 66% YoY and by 11% from the previous quarter
MAIA Biotechnology's operating income has decreased by 46% YoY and by 12% from the previous quarter

Price vs fundamentals

How does MAIA's price correlate with its fundamentals

Growth

What is MAIA Biotechnology's growth rate over time

Valuation

What is MAIA Biotechnology stock price valuation
P/E
N/A
P/B
3.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 9% year-on-year but it rose by 7% since the previous quarter
The stock's price to book (P/B) is 99% less than its last 4 quarters average of 312.6
MAIA's equity is down by 26% since the previous quarter

Efficiency

How efficient is MAIA Biotechnology business performance
The company's return on equity has surged by 54% YoY and by 26% QoQ
The return on assets is up by 17% year-on-year and by 12% since the previous quarter

Dividends

What is MAIA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MAIA.

Financial health

How did MAIA Biotechnology financials performed over time
MAIA's total assets has surged by 156% year-on-year but it is down by 20% since the previous quarter
MAIA Biotechnology's quick ratio has soared by 119% YoY but it has decreased by 19% from the previous quarter
The debt is 100% less than the equity
MAIA's equity is down by 26% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.